Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
35.57
-0.25 (-0.70%)
At close: Mar 20, 2026, 4:00 PM EDT
36.00
+0.43 (1.21%)
After-hours: Mar 20, 2026, 6:49 PM EDT
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $3.72 billion as of March 20, 2026. Its market cap has increased by 17.34% in one year.
Market Cap
3.72B
Enterprise Value
2.75B
1-Year Change
17.34%
Ranking
Category
Stock Price
$35.57
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $563.93M to $3.72B, an increase of 560.44%. That is a compound annual growth rate of 27.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 3.72B | -15.69% |
| Dec 31, 2025 | 4.42B | -6.84% |
| Dec 31, 2024 | 4.74B | 99.51% |
| Dec 29, 2023 | 2.38B | 141.36% |
| Dec 30, 2022 | 984.73M | -26.50% |
| Dec 31, 2021 | 1.34B | 188.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ligand Pharmaceuticals | 4.08B |
| Viking Therapeutics | 3.74B |
| Corcept Therapeutics | 3.68B |
| Centessa Pharmaceuticals | 3.64B |
| ACADIA Pharmaceuticals | 3.54B |
| Dianthus Therapeutics | 3.46B |
| Structure Therapeutics | 3.44B |
| ADMA Biologics | 3.41B |